Whales with a lot of money to spend have taken a noticeably bearish stance on AbbVie.
Looking at options history for AbbVie ABBV we detected 9 trades.
If we consider the specifics of each trade, it is accurate to state that 22% of the investors opened trades with bullish expectations and 66% with bearish.
From the overall spotted trades, 2 are puts, for a total amount of $609,240 and 7, calls, for a total amount of $568,472.
Predicted Price Range
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $100.0 to $210.0 for AbbVie over the last 3 months.
Volume & Open Interest Development
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for AbbVie's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of AbbVie's whale trades within a strike price range from $100.0 to $210.0 in the last 30 days.
AbbVie Option Volume And Open Interest Over Last 30 Days
Significant Options Trades Detected:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABBV | PUT | TRADE | NEUTRAL | 01/15/27 | $17.25 | $15.85 | $16.5 | $160.00 | $577.5K | 312 | 350 |
| ABBV | CALL | TRADE | BULLISH | 04/17/25 | $2.49 | $2.37 | $2.48 | $185.00 | $235.6K | 179 | 953 |
| ABBV | CALL | TRADE | BEARISH | 06/20/25 | $8.7 | $8.5 | $8.5 | $175.00 | $85.0K | 760 | 100 |
| ABBV | CALL | SWEEP | BEARISH | 02/21/25 | $3.3 | $3.15 | $3.17 | $175.00 | $83.0K | 1.4K | 305 |
| ABBV | CALL | TRADE | BEARISH | 01/15/27 | $10.85 | $9.9 | $10.15 | $210.00 | $48.7K | 748 | 50 |
About AbbVie
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
Following our analysis of the options activities associated with AbbVie, we pivot to a closer look at the company's own performance.
Where Is AbbVie Standing Right Now?
- Currently trading with a volume of 2,537,833, the ABBV's price is up by 0.01%, now at $170.69.
- RSI readings suggest the stock is currently may be approaching oversold.
- Anticipated earnings release is in 7 days.
What Analysts Are Saying About AbbVie
Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $211.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access. * Maintaining their stance, an analyst from Truist Securities continues to hold a Buy rating for AbbVie, targeting a price of $211.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for AbbVie with Benzinga Pro for real-time alerts.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
